59 related articles for article (PubMed ID: 17986096)
1. Serum levels of glial fibrillary acidic protein correlate to tumour volume of high-grade gliomas.
Brommeland T; Rosengren L; Fridlund S; Hennig R; Isaksen V
Acta Neurol Scand; 2007 Dec; 116(6):380-4. PubMed ID: 17986096
[TBL] [Abstract][Full Text] [Related]
2. GFAP splice variants fine-tune glioma cell invasion and tumour dynamics by modulating migration persistence.
Uceda-Castro R; van Asperen JV; Vennin C; Sluijs JA; van Bodegraven EJ; Margarido AS; Robe PAJ; van Rheenen J; Hol EM
Sci Rep; 2022 Jan; 12(1):424. PubMed ID: 35013418
[TBL] [Abstract][Full Text] [Related]
3. Liquid biopsies for early diagnosis of brain tumours:
Blee JA; Liu X; Harland AJ; Fatania K; Currie S; Kurian KM; Hauert S
J R Soc Interface; 2022 Aug; 19(193):20220180. PubMed ID: 35919979
[TBL] [Abstract][Full Text] [Related]
4. Blood GFAP as an emerging biomarker in brain and spinal cord disorders.
Abdelhak A; Foschi M; Abu-Rumeileh S; Yue JK; D'Anna L; Huss A; Oeckl P; Ludolph AC; Kuhle J; Petzold A; Manley GT; Green AJ; Otto M; Tumani H
Nat Rev Neurol; 2022 Mar; 18(3):158-172. PubMed ID: 35115728
[TBL] [Abstract][Full Text] [Related]
5. Covid-19 interface with drug misuse and substance use disorders.
Cisneros IE; Cunningham KA
Neuropharmacology; 2021 Oct; 198():108766. PubMed ID: 34454912
[TBL] [Abstract][Full Text] [Related]
6. Blood-Based Biomarkers for Glioma in the Context of Gliomagenesis: A Systematic Review.
Ali H; Harting R; de Vries R; Ali M; Wurdinger T; Best MG
Front Oncol; 2021; 11():665235. PubMed ID: 34150629
[TBL] [Abstract][Full Text] [Related]
7. Glioblastoma: Is There Any Blood Biomarker with True Clinical Relevance?
Linhares P; Carvalho B; Vaz R; Costa BM
Int J Mol Sci; 2020 Aug; 21(16):. PubMed ID: 32823572
[TBL] [Abstract][Full Text] [Related]
8. Feasibility and safety of focused ultrasound-enabled liquid biopsy in the brain of a porcine model.
Pacia CP; Zhu L; Yang Y; Yue Y; Nazeri A; Michael Gach H; Talcott MR; Leuthardt EC; Chen H
Sci Rep; 2020 May; 10(1):7449. PubMed ID: 32366915
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of microRNA-103a inhibits the activation of astrocytes in hippocampus tissues and improves the pathological injury of neurons of epilepsy rats by regulating BDNF.
Zheng P; Bin H; Chen W
Cancer Cell Int; 2019; 19(1):109. PubMed ID: 31049031
[TBL] [Abstract][Full Text] [Related]
10. Pre- and early postoperative GFAP serum levels in glioma and brain metastases.
Baumgarten P; Quick-Weller J; Gessler F; Wagner M; Tichy J; Forster MT; Foerch C; Seifert V; Mittelbronn M; Senft C
J Neurooncol; 2018 Sep; 139(3):541-546. PubMed ID: 29797180
[TBL] [Abstract][Full Text] [Related]
11. A novel functional polymorphism of
Wang J; Wang ML; Wang CH; Sun SY; Zhang HB; Jiang YY; Xu QW; Wang Y; Gu SX
Aging (Albany NY); 2018 May; 10(5):988-999. PubMed ID: 29746255
[TBL] [Abstract][Full Text] [Related]
12. Circulating CD9+/GFAP+/survivin+ exosomes in malignant glioma patients following survivin vaccination.
Galbo PM; Ciesielski MJ; Figel S; Maguire O; Qiu J; Wiltsie L; Minderman H; Fenstermaker RA
Oncotarget; 2017 Dec; 8(70):114722-114735. PubMed ID: 29383115
[TBL] [Abstract][Full Text] [Related]
13. Molecular Determinants of Malignant Brain Cancers: From Intracellular Alterations to Invasion Mediated by Extracellular Vesicles.
Schiera G; Di Liegro CM; Di Liegro I
Int J Mol Sci; 2017 Dec; 18(12):. PubMed ID: 29261132
[TBL] [Abstract][Full Text] [Related]
14. A Systematic Review of the Usefulness of Glial Fibrillary Acidic Protein for Predicting Acute Intracranial Lesions following Head Trauma.
Luoto TM; Raj R; Posti JP; Gardner AJ; Panenka WJ; Iverson GL
Front Neurol; 2017; 8():652. PubMed ID: 29255443
[TBL] [Abstract][Full Text] [Related]
15. Serum concentrations of glial fibrillary acidic protein (GFAP) do not indicate tumor recurrence in patients with glioblastoma.
Vietheer JM; Rieger J; Wagner M; Senft C; Tichy J; Foerch C
J Neurooncol; 2017 Oct; 135(1):193-199. PubMed ID: 28717884
[TBL] [Abstract][Full Text] [Related]
16. Prognostic value of the S100B protein in newly diagnosed and recurrent glioma patients: a serial analysis.
Holla FK; Postma TJ; Blankenstein MA; van Mierlo TJM; Vos MJ; Sizoo EM; de Groot M; Uitdehaag BMJ; Buter J; Klein M; Reijneveld JC; Heimans JJ
J Neurooncol; 2016 Sep; 129(3):525-532. PubMed ID: 27401156
[TBL] [Abstract][Full Text] [Related]
17. Prospective evaluation of serum glial fibrillary acidic protein (GFAP) as a diagnostic marker for glioblastoma.
Tichy J; Spechtmeyer S; Mittelbronn M; Hattingen E; Rieger J; Senft C; Foerch C
J Neurooncol; 2016 Jan; 126(2):361-9. PubMed ID: 26518540
[TBL] [Abstract][Full Text] [Related]
18. Serum levels of GFAP and EGFR in primary and recurrent high-grade gliomas: correlation to tumor volume, molecular markers, and progression-free survival.
Kiviniemi A; Gardberg M; Frantzén J; Parkkola R; Vuorinen V; Pesola M; Minn H
J Neurooncol; 2015 Sep; 124(2):237-45. PubMed ID: 26033547
[TBL] [Abstract][Full Text] [Related]
19. Glial fibrillary acidic protein: from intermediate filament assembly and gliosis to neurobiomarker.
Yang Z; Wang KK
Trends Neurosci; 2015 Jun; 38(6):364-74. PubMed ID: 25975510
[TBL] [Abstract][Full Text] [Related]
20. Liquid biopsies in patients with diffuse glioma.
Best MG; Sol N; Zijl S; Reijneveld JC; Wesseling P; Wurdinger T
Acta Neuropathol; 2015 Jun; 129(6):849-65. PubMed ID: 25720744
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
